Health
NFL Greats and Novartis Tackle Prostate Cancer Myths at Super Bowl LX: "Relax, It's a Blood Test"
Novartis, a leading global innovative medicines company and the official pharmaceutical partner of the NFL, today announced the launch of "Relax, it's a blood test," a new national prostate cancer awareness initiative that kicks off with a commercial airing during Super Bowl LX on February 8, 2026.
About this update from Novartis Ag
[{"type":"list","items":[{"val":[{"type":"text","content":"NFL Icons Coach Bruce Arians, Rob Gronkowski, George Kittle and more partner with Novartis to prioritize early prostate cancer detection","length":136,"tagName":"p"}]},{"val":[{"type":"text","content":"One in eight men will face prostate cancer1, yet fear and avoidance of digital rectal exams keep men from getting screened2 ","length":123,"tagName":"p"}]},{"val":[{"type":"text","content":"Novartis launches new awareness initiative timed to Super Bowl LX, driving conversation to make critical health information clearer, accessible and relevant","length":156,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":415,"olType":false},{"type":"text","content":"EAST HANOVER, N.J., Jan. 29, 2026 /PRNewswire/ -- Novartis, a leading global innovative medicines company and the official pharmaceutical partner of the NFL, today announced the launch of "Relax, it's a blood test," a new national prostate cancer awareness initiative that kicks off with a commercial airing during Super Bowl LX on February 8, 2026.","length":383,"tagName":"p"},{"id":"lMTcZb48aVU","subtype":"videoIframe","type":"youtube","url":"https://www.youtube.com/embed/lMTcZb48aVU","width":560,"height":315,"anchorId":"37a7903e-c641-5920-b1aa-6dde0d96eaa3"},{"type":"text","content":"Prostate cancer is the most commonly diagnosed cancer and second leading cause of cancer death among men in the United States. Early detection leads to a greater than 99% relative 5-year survival rate, yet many men avoid prostate cancer screening, and 60% mistakenly believe that it requires an invasive digital rectal exam (DRE).1,2,3,4 The reality is the first step is a simple prostate-specific antigen (PSA) blood test.","length":443,"tagName":"p"},{"type":"text","content":""Relax, it's a blood test" cuts through stigma and addresses the anxieties and misperceptions that can cause men to avoid prostate cancer screening. Novartis has partnered with leading patient advocacy organizations, including the American Cancer Society, Malecare, National Alliance of State Prostate Cancer Coalitions, Prostate Cancer Foundation, Prostate Health Education Network, ZERO Prostate Cancer, and others to help shape the campaign and drive increased PSA screenings. The initiative aims to demystify the process, em...